In this issue of Blood, Stilgenbauer and colleagues report on the prognostic and predictive value of gene mutations assessed prospectively in patients with chronic lymphocytic leukemia (CLL) treated with first-line chemoimmunotherapy. © 2014 by The American Society of Hematology.
CITATION STYLE
Wiestner, A. (2014, May 22). Predicting treatment outcomes in CLL. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2014-04-565325
Mendeley helps you to discover research relevant for your work.